---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-008100"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:46:35.516864+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Passage Bio transfers listing to Nasdaq Capital Market; granted 180-day extension to meet $1.00 bid price

## Summary
- Received Nasdaq deficiency notice on Aug 1, 2024 for bid price below $1.00 for 30 consecutive days.
- Nasdaq approved transfer to Capital Market effective Jan 30, 2025; stock continues trading under PASG.
- Granted additional 180-day compliance period until July 28, 2025 to regain $1.00 minimum bid price.
- Company will monitor and consider options including reverse stock split if necessary.

## SEC filing metadata
- accession: 0001104659-25-008100
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465925008100/0001104659-25-008100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465925008100/tm254971d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-008100
- JSON: https://secwatch.observer/filing/0001104659-25-008100.json
- Plain text: https://secwatch.observer/filing/0001104659-25-008100.txt

## Source-grounded claims
- claim_id: 1aea8fc8c209ffeb02df79faa0447fad019c01e2
  claim: Passage BIO, Inc. received a nasdaq extension granted notice regarding minimum bid price.
  evidence_excerpt: January 29, 2025, the Nasdaq Listing Qualifications department approved the Company’s request to transfer the listing of the Company’s shares of common stock from The Nasdaq Global Select Market to The Nasdaq Capital Mar
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465925008100/0001104659-25-008100-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.